KR101404309B1 - The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck - Google Patents
The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck Download PDFInfo
- Publication number
- KR101404309B1 KR101404309B1 KR1020120137489A KR20120137489A KR101404309B1 KR 101404309 B1 KR101404309 B1 KR 101404309B1 KR 1020120137489 A KR1020120137489 A KR 1020120137489A KR 20120137489 A KR20120137489 A KR 20120137489A KR 101404309 B1 KR101404309 B1 KR 101404309B1
- Authority
- KR
- South Korea
- Prior art keywords
- herb medicine
- weight
- medicine group
- herb
- parts
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 229940124594 traditional oriental medicine Drugs 0.000 title 1
- 238000000855 fermentation Methods 0.000 claims abstract description 39
- 230000004151 fermentation Effects 0.000 claims abstract description 35
- 241000196324 Embryophyta Species 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 18
- 235000000346 sugar Nutrition 0.000 claims abstract description 18
- 235000014214 soft drink Nutrition 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 6
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 6
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 67
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 229930091371 Fructose Natural products 0.000 claims description 10
- 239000005715 Fructose Substances 0.000 claims description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 8
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 241001105098 Angelica keiskei Species 0.000 claims description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims description 4
- 235000014066 European mistletoe Nutrition 0.000 claims description 4
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 4
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 239000006001 Methyl nonyl ketone Substances 0.000 claims description 3
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 claims description 3
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 claims description 2
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 230000002363 herbicidal effect Effects 0.000 claims description 2
- 239000004009 herbicide Substances 0.000 claims description 2
- 241000221012 Viscum Species 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 13
- 239000007788 liquid Substances 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 7
- 239000000796 flavoring agent Substances 0.000 abstract description 6
- 235000019634 flavors Nutrition 0.000 abstract description 6
- 235000008216 herbs Nutrition 0.000 abstract 2
- 244000167222 Acanthopanax sessiliflorus Species 0.000 abstract 1
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 abstract 1
- 240000001810 Angelica gigas Species 0.000 abstract 1
- 235000018865 Angelica gigas Nutrition 0.000 abstract 1
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 abstract 1
- 241000951471 Citrus junos Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 244000010000 Hovenia dulcis Species 0.000 abstract 1
- 235000008584 Hovenia dulcis Nutrition 0.000 abstract 1
- 244000018795 Prunus mume Species 0.000 abstract 1
- 235000011158 Prunus mume Nutrition 0.000 abstract 1
- 235000013502 Pyrus japonica Nutrition 0.000 abstract 1
- 241001505096 Rhamnus davurica Species 0.000 abstract 1
- 241000221013 Viscum album Species 0.000 abstract 1
- 241001247821 Ziziphus Species 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 description 26
- 230000009471 action Effects 0.000 description 14
- 235000013399 edible fruits Nutrition 0.000 description 13
- 235000013361 beverage Nutrition 0.000 description 12
- 150000007524 organic acids Chemical class 0.000 description 12
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 11
- -1 decursinol Chemical compound 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 8
- 229930182470 glycoside Natural products 0.000 description 8
- 150000002338 glycosides Chemical class 0.000 description 8
- 229940093915 gynecological organic acid Drugs 0.000 description 8
- 235000005985 organic acids Nutrition 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 150000008163 sugars Chemical class 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000001671 coumarin Nutrition 0.000 description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229960000956 coumarin Drugs 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 241000233614 Phytophthora Species 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 244000134540 Polymnia sonchifolia Species 0.000 description 3
- 235000003406 Polymnia sonchifolia Nutrition 0.000 description 3
- 244000152640 Rhipsalis cassutha Species 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 235000007240 daidzein Nutrition 0.000 description 3
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- WZUODJNEIXSNEU-UHFFFAOYSA-N 2-Hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(O)=C1 WZUODJNEIXSNEU-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- PFCNGVAJKSGUNN-UHFFFAOYSA-N CCC(C)(O)c1cc(OC)c(C)c2OC(=O)c3c(C)cc(O)c(Cl)c3Oc12 Chemical compound CCC(C)(O)c1cc(OC)c(C)c2OC(=O)c3c(C)cc(O)c(Cl)c3Oc12 PFCNGVAJKSGUNN-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000195955 Equisetum hyemale Species 0.000 description 2
- 208000001034 Frostbite Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 240000007058 Halophila ovalis Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000021403 cultural food Nutrition 0.000 description 2
- ZGFASEKBKWVCGP-UHFFFAOYSA-N cyclocoumarol Chemical compound C12=CC=CC=C2OC(=O)C2=C1OC(OC)(C)CC2C1=CC=CC=C1 ZGFASEKBKWVCGP-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 2
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 2
- 229920005610 lignin Chemical class 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000590 phytopharmaceutical Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- 229930013799 (-)-catechin Natural products 0.000 description 1
- PFTAWBLQPZVEMU-HIFRSBDPSA-N (-)-catechin Chemical compound C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-HIFRSBDPSA-N 0.000 description 1
- 235000007331 (-)-catechin Nutrition 0.000 description 1
- OUCUOMVLTQBZCY-BYPYZUCNSA-N (2s)-1-azaniumylpyrrolidine-2-carboxylate Chemical compound NN1CCC[C@H]1C(O)=O OUCUOMVLTQBZCY-BYPYZUCNSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Chemical compound CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YRYCIFUZSUMAAY-UHFFFAOYSA-N (RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline Chemical class N1CCC2=CC=CC=C2C1CC1=CC=CC=C1 YRYCIFUZSUMAAY-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000580482 Acidobacteria Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001059810 Cantharellula umbonata Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- PHHAXWBLJNBVNS-UHFFFAOYSA-N Isoglycycoumarin Natural products C=1C=2C(OC)=C3CCC(C)(C)OC3=CC=2OC(=O)C=1C1=CC=C(O)C=C1O PHHAXWBLJNBVNS-UHFFFAOYSA-N 0.000 description 1
- FZKBNCDAGYDHTP-OBLZSLNYSA-N Isoquercetrin Chemical compound O[C@H]1[C@@H](O)[C@H](O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-OBLZSLNYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 229930192007 acanthoside Natural products 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000003732 agents acting on the eye Substances 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- CXQWRCVTCMQVQX-UHFFFAOYSA-N cis-dihydroquercetin Natural products O1C2=CC(O)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- VVEKCQAFOLKNKB-UHFFFAOYSA-N emodine Natural products C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O VVEKCQAFOLKNKB-UHFFFAOYSA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000022760 infectious otitis media Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940023490 ophthalmic product Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XGPBRZDOJDLKOT-UHFFFAOYSA-N praeruptorin A Natural products C1=CC(=O)OC2=C1C=CC1=C2C(OC(C)=O)C(OC(=O)C(C)=CC)C(C)(C)O1 XGPBRZDOJDLKOT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000013522 vodka Nutrition 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/46—Preservation of non-alcoholic beverages by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 어성초를 비롯한 식물생약재를 이용한 청량음료의 제조방법에 관한 것으로 보다 상세하게는 건강에 유효한 다양한 약리성분이 함유된 어성초, 당귀, 두충, 오갈피, 겨우살이로 구성되는 식물생약재를 발효시킨 발효액과 그 발효잔사를 고압하에서 고온으로 열처리한 물 추출액 그리고 식감을 향상시킴으로서 풍미를 갖게 하는 천연당과 유기산이 다향 함유된 갈근, 지구자, 서리자, 대조, 모과, 산사, 매실, 유자를 각각 동일으로 배합한 제2식물생약재군의 발효액, 항산화제, 아스코르빈산으로 조성되는 청량음료제조방법에 관한 것이다. 근년에 이으러 괄목할만한 산업의 발전과 더불어 국민 소득의 증대에 따른 생활수준의 향상으로 음식문화의 패턴이 크게 변화되면서 특히 지방질의 육류 섭취량이 많아진데다 인스턴트 식품의 이용률이 높아짐으로서 이에 따른 문제점들로 비만증이 늘어나고 각종성인병 발병률이 높아짐으로서 사회적인 문제점으로 대두되고 있다. 이와 같은 상황을 인식하게 됨으로서 최근에는 건강지향적인 차원에서 천연식품 및 천연음료를 선호하는 경향으로 다시 음식 문화 패턴에 변화를 가져오게 됨에 따라 친환경적인 건강 천연 식품에 관한 연구가 활발하게 진행되고 이에 따른 관련 제품들도 출시되고 있다.The present invention relates to a method for producing a soft drink using a plant herbal medicine including a herbal composition, and more particularly, to a method for producing a soft drink using a plant herb medicine comprising a herbal composition comprising a variety of pharmacological ingredients effective for health and a herbal medicine comprising ferrets, The fermentation residue is heat treated at high temperature under high pressure. The extract is mixed with the same natural flavor enhancer and flavor enhancer, such as purpurogeum, diatomaceous earth, frost, contrast, quince, An antioxidant, and ascorbic acid in a second herb medicine group. In recent years, with the development of remarkable industry, the pattern of food culture has been greatly changed due to the improvement of the living standard due to the increase of the national income. Especially, the fat intake of the fat is increased and the utilization rate of the instant food is increased. Obesity is increasing and the incidence of various adult diseases is rising, which is a social problem. In recent years, as a result of recognizing such a situation, the tendency to prefer natural foods and natural beverages in a health-oriented aspect has led to changes in food culture patterns, so that research on environmentally friendly healthy foods has been actively conducted Related products are also being released.
본 발명 또한 상기와 같은 추세에 따른 천연 식품 개발의 일환으로 인체에 유효한 약리성분이 다량 함유되어 있는 식물생약재는 물론 우수한 식감으로 풍미를 갖게하는 천연당과 유기산이 다량 함유된 식물생약재를 이용한 건강식품으로서의 청량음료를 제공함에 목적이 있다. As a part of the development of natural foods according to the above trends, the present invention also relates to a method for producing a natural health food using a plant herbal medicine containing a large amount of natural sugars and organic acids, The purpose is to provide soft drinks.
본 발명에서 시도하는 식물생약재를 이용한 청량음료는 통상적으로 약리적으로 유용한 성분이 다양한 식물생약재들과 천연당과 유기산이 다량 함유되어 풍미를 갖게 하는 식물생약재에 근거를 두고 있으며 전자의 생약재들은 어성초, 당귀, 두충, 오갈피, 겨우살이 등의 식물생약재들이라 할 수 있으며 후자는 갈근, 지구자, 서리자, 산사, 대조, 모과, 매실, 유자 중에서 선택되는 하나 이상의 식물생약재라 할 수 있고 또한 발효공정과 고압 하에 고온 열처리 공정을 병행함으로서 식물생약재에 함유된 유용한 성분들의 추출률을 최대화 함에도 목적을 두고 있으며 그 밖에 본원 출원 발명의 선행기술인 등록 특허공보(등록번호:79084호)의 “어성초드링크”를 제품화하는 과정에서 발생된 미흡한 문제점들을 그간의 축적된 기술을 토대로 하여 본원 출원 발명의 모체가 되는 선행기술을 개량 보완한 발명이라고도 할 수 있다. The soft drinks using the plant herb medicines of the present invention are based on herbal medicines which are generally pharmacologically useful as various phytopharmaceuticals and a large amount of natural sugars and organic acids to impart flavor, The latter may be one or more herbal medicines selected from the group consisting of Puerariae radicifolia, Plasmodium falciparum, Seedlings, Sansa, Contrasts, Moraceae, Plum and Citron, and may be a fermentation process and a high temperature heat treatment The present invention also aims at maximizing the extraction rate of useful components contained in plant herbal medicines by carrying out the process of the present invention. In addition, the present invention is also directed to a process for producing a medicinal herb medicine Based on the accumulated technology, It can be said that the present invention has been improved and supplemented with the prior art which becomes the matrix of the invention.
종래에도 본 발명에서와 같이 식물생약재를 이용한 건강식품이나 음료로 개발된 제품들이 출시되고 있고 특허공보에도 다수의 제품들이 소개되고 있으며 그 일예로서 국내등록특허공보(등록번호:10-0440493호)에는 택사 건강음료 및 그 제조 방법에 관한 기술 내용이 소개되고 있으며 기술 내용인즉 택사, 대추, 구기자, 오미자를 포함하는 생약재에 물을 첨가하여 80℃에서 2회에 걸쳐 5시간 추출 농축하여 택사추출물을 포함하는 생약재 추출물을 제조하고 각 생약재 추출물을 일정 비율로 혼합한 혼합추출물에 부원료인 사과과즙 구연산, 비타민, 액상과당, 저당을 일정 비율로 배합한 부원료를 첨가한 시료에 소량의 향료와 물을 첨가하여 여과한 여액을 93℃에서 살균처리하고 용기에 넣어 80℃에서 살균한 택사 건강음료의 제조방법에 관한 것으로 이상과 같은 택사를 비롯한 식물생약재는 각 식물생약재들이 함유하고 있는 약리성분에 따라 그 기능과 작용을 발휘하겠지만 일반적으로 식물생약재에는 추출과정에서 물의 비점 이상의 온도에서도 용출되지 않는 유용한 약리성분 및 영양성분이 많아 추출 후 식물생약재 잔사에 잔존하게 됨으로서 유효성분의 손실이 크다고 할 수 있다. 더욱이 상기 발명에서와 같이 낮은 온도에서 추출할 경우는 용출되어 추출되는 추출률이 더욱 떨어지고 사과과즙 구연산, 비타민, 액상과당, 천연당의 부원료를 상기 식물생약재의 추출액에 단순 첨가함으로서 액상 음료의 변질의 소지가 있고 액상음료의 균질성과 안정성이 결여됨으로서 음료에 침전물이나 부유물이 발생하는 등 액상음료의 상분리가 발생할 수 있다.Heretofore, as described in the present invention, products developed as health foods or beverages using plant herbal medicines have been released and many products have been introduced in the patent publications. As an example thereof, Korean Patent Registration No. 10-0440493 The contents of the technical content of the tax health drink and the manufacturing method thereof are introduced, and water is added to the herbal medicine including taxa, jujube, gugija and omija, and extracted and concentrated at 80 ° C for 5 hours for 2 hours to contain taxa extract And a small amount of fragrance and water were added to a sample to which a supplementary ingredient containing a certain ratio of apple juice citric acid, vitamin, liquid fructose, and a certain amount of a mortar was added to a mixed extract prepared by mixing each herbal extract with a certain ratio The present invention relates to a method for producing a medical health drink by sterilizing filtered filtrate at 93 ° C and sterilization at 80 ° C in a container And phytophthora such as Phytophthora such as Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophthora Phytophagus After extraction, it remains in the residue of the plant herbal medicine, so that the loss of the active ingredient is large. Further, when the extract is extracted at a low temperature as in the above-mentioned invention, the extraction rate to be eluted and extracted is further lowered, and the additive of apple juice citric acid, vitamin, liquid fructose and natural sugar is simply added to the extract of the plant herbal medicine, And the homogeneity and stability of the liquid beverage are lacked, so that a phase separation of the liquid beverage may occur, for example, precipitates or suspended matters occur in the beverage.
종래기술의 다른 예로서 국내공개특허공보(공개번호 특 2002-8725호)에는 한방건강식음료 감비천 및 그 제조방법에 관한 기술내용으로 호박, 생강, 율무, 감초, 질경, 백출, 지리, 시호, 계피, 택사, 대추, 치자의 각 식물생약재를 일정 비율로 혼합한 식물생약재 재료에 물을 첨가 온도 80~100℃ 범위를 유지한 상태에서 1~5시간 열처리한 후 압착하여 여과한 추출액을 밀폐포장한 건강식음료의 제조방법에 관한 것이나 이는 종래 민간에서 전래되어온 제비차(감비천)를 얻는 방법과 같이 호박에 각종 식물생약재를 첨가 혼합하고 일정량의 물을 첨가 탕기에서 달인 후 삼백초를 넣어 압착 하에 얻어지는 탕기 달인 액(추출액)으로 사용하는 재료나 방법이 아주 유사하다고 할 수 있다.As another example of the prior art, Korean Patent Laid-open Publication No. 2002-8725 discloses a method of manufacturing a sweet potato, Water is added to a plant herbal medicine material mixed with a certain ratio of each phytomedicin of cinnamon, phytase, jujube, and gardenia, heat treated for 1 to 5 hours in a temperature range of 80 to 100 ° C., A method for manufacturing a health food and beverage, which is a method for obtaining a swallow (persimmon) which has been imported from the private sector in the past. Various kinds of herbal medicines are added to pumpkin, and a certain amount of water is added thereto. It can be said that the materials and methods used in the tanggisin extract (extract) are very similar.
또 다른 종래기술로서 국내등록특허공보(등록번호 제890473호)에는 “야콘을 주재로한 건강음료의 제조 방법”이 소개되고 있다. 기술의 구성은 야콘의 덩이뿌리의 껍질을 벗긴 근피와 줄기, 야콘의 잎을 건조하고 절단편에 물을 첨가 고온 증숙기에서 30분간 끓여 압착한 추출액 40%에 키토산을 함유한 수성액체 60%를 혼합하여 살균 포장한 건강음료라 할 수 있으나 액상의 키토산을 첨가한 음료는 음용하기가 극히 역겹고 불편함으로서 약리적인 기능과 작용이 어떠하든 음료수의 기본 요건의 하나인 맛깔스러운 풍미를 기대할 수 없는 음료라 할 수 있다. 그 밖에도 식물생약재를 이용한 제품화된 기능성 음료들이 출시되고 있고 특허 등록된 음료수들이 다수 소개되고 있으나 사용되는 각 식물생약재에 이미 알려져 있는 고유의 성분이나 성분에 따른 기능과 작용을 얻기 위해 식물생약재에 함유된 성분을 단순히 얻기 위해 식물생약재에 함유된 성분을 단순히 추출하는 정도의 기술 수준으로서 처리과정을 통해 풍미가 우수한 유기산의 생성으로 맛을 향상시키는 처리를 하거나 식물생약재에 함유된 유용한 약리성분이나 영양성분이 추출효율을 향상시키는 처리수단, 변질을 방지수단, 보존성 향상을 위한 기술 수준에 있어서는 아직도 개발의 여지가 많은 분야라 하겠다.As another conventional technique, a registered trademark (Registration No. 890473) discloses " a method for manufacturing a health drink based on yacon ". The composition of the technique is to remove the peeled roots of yacon root, stem and leaves of yacon and add water to the cut pieces. 40% of the extracted juice is boiled for 30 minutes in a hot steam boiler and 60% of the aqueous liquid containing chitosan It can be said that it is a health drink which is mixed and sterilized packed. However, it is very discomfortful and uncomfortable to drink the liquid chitosan-added beverage, so that the pharmacological function and the action of the beverage can not be expected as a basic flavor . In addition, commercialized functional beverages using plant herbal medicines are being marketed, and a number of patented beverages have been introduced. However, in order to obtain functions and actions according to the inherent ingredients and components already known to each herbal medicine used, To obtain the ingredients simply extract the ingredients contained in the plant herbal medicines as a technology level of processing through the process to improve the taste of the production of high-quality organic acids to improve the treatment of the pharmacological ingredients and nutrients contained in herbal medicines There is still much room for development in terms of processing means for improving extraction efficiency, means for preventing deterioration, and technology for improving preservability.
본 발명은 식물생약재를 발효시킴으로서 물에 의한 고온 추출방법으로 쉽게 용출될 수 없는 약리성분 및 영양성분을 얻을 수 있고 발효숙성과정에서 식감을 높이는 수종의 유기산을 생성시킬 수 있으며 또한 식물생약재의 추출 잔사를 다시 100℃이상의 고온 열처리로 추출함으로서 식물생약재에 함유된 유효성분을 효율적으로 추출할 수 있고 음료수로서의 우수한 식감을 확보할 수 있는 식물생약재를 이용한 청량음료를 제공함에 있다.By fermenting a plant herb medicine, it is possible to obtain a pharmacological component and a nutrient component that can not be easily eluted by a high-temperature extraction method using water, and can produce a variety of organic acids that enhance the texture during the fermentation and aging process. Is extracted by a high temperature heat treatment at a temperature of 100 ° C or higher to efficiently extract an effective ingredient contained in a plant herbal medicine and to secure a good texture as a beverage.
어성초를 고압수증기로 처리하여 산화시킴으로서 생선비린내와 유사한 불쾌한 냄새를 제거한 어성초와 그 밖에 당귀, 두충, 오갈피, 겨우살이로 구성된 제1식물생약재군 혼합물에 동일양의 설탕 또는 과당을 첨가한 것에 2배의 정수를 첨가하여 발효재료를 얻고 이를 온도 25±2℃ 유지되는 밀폐용기에서 20~25일간 발효시킨 후 압착하여 제1식물생약재군의 발효잔사를 제거하여 제1식물생약재군의 발효액을 얻고 상기 제1식물생약재군의 발효잔사에 4배중량의 정수를 첨가해서 온도 115~120℃로 유지시킬 수 있는 고압부에서 1시간 열처리한 다음 대기압 하에서 증비하여 전체 중량의 20%가 될 때까지 농축하고 압착하여 제1식물생약재군의 발효잔사 추출액을 얻고 별도로 지구자, 서리자, 대조, 갈근, 산사, 모과, 매실, 유자를 각각 동일양으로 배합한 제2식물생약재군의 혼합물에 동량의 설탕 또는 과당을 첨가한 발효재료에 2배 중량의 정수를 첨가하여 온도 20±2℃로 유지된 밀폐용기에서 13~15일간 혐기성 발효로 발효 종료시킨 다음 압착하여 발효잔사를 분리하고 제2식물생약재군의 발효액을 얻은 다음 상기 제1식물생약재군의 발효액, 제1식물생약재군의 발효잔사로 고압 하에 고온 열처리한 추출액, 제2식물생약재군의 발효액과 항산화제, 아스코르빈산을 일정 비율로 조성해서 된 어성초를 비롯한 식물생약재를 이용한 청량음료의 제조 방법이라 할 수 있다.It was found that the addition of the same amount of sugar or fructose to the first plant herb medicine mixture, which consists of the herringbone which has been treated with high-pressure steam to remove the unpleasant smell similar to the fish smell, and the other herbaceous herb, And fermenting the fermented material in a closed vessel maintained at a temperature of 25 ± 2 ° C. for 20 to 25 days and then pressing it to remove the fermentation residue of the first herb medicine group to obtain a fermentation broth of the first herb medicine group, 1 was added to the fermentation residue of the plant herb medicine group and heat-treated for 1 hour at a high-pressure portion where the temperature could be maintained at 115-120 ° C. Then, the mixture was concentrated under atmospheric pressure and concentrated to 20% A second fermented residue extract of the first herb medicine group is obtained, and a second extract of the second herb extract is prepared by separately mixing the extracts of the first herb, the frog, the control, the crab, the horsetail, the quince, To the fermentation material added with the same amount of sugar or fructose to the mixture of the herbal medicines, 2 times the weight of purified water was added and the fermentation was terminated by anaerobic fermentation in a closed container maintained at a temperature of 20 ± 2 ° C for 13 to 15 days, A fermentation broth of the second herb medicine group, an extract solution obtained by subjecting the fermentation broth of the first herb medicine group and the first herb medicine group to high temperature heat treatment under high pressure, a fermentation broth of the second herb medicine group and an antioxidant, It can be said that it is a method of producing a soft drink using a plant herbal medicine including herringbone which is constituted by a certain ratio of corbic acid.
본 발명에 의하여 제조된 청량음료는 다양한 질병성 세균에 대한 탁월한 항균성을 가지며 장복하면 염증성 질병이나 피부질병을 예방 및 치유할 수 있고 건강한 피부를 유지할 수 있으며 각종 천연당과 질 좋은 유기산이 첨가됨으로써 탁월한 식감을 확보할 수 있어 풍미를 즐길 수 있는 청량음료라 할 수 있다.The soft drink produced by the present invention has excellent antimicrobial activity against various disease bacteria and can prevent and cure inflammatory diseases and skin diseases when it is bloomed, can maintain a healthy skin, and can be provided with various natural sugars and high quality organic acid, And can enjoy the flavor can be said to be a soft drink.
본 발명은 다양한 약리성분이 함유된 어성초, 당귀, 오갈피, 두충, 겨우살이로 구성된 제1식물생약재군의 발효액과 제1식물생약재군의 발효물 잔사를 고압 하에 고온 처리한 추출액, 그리고 식감을 향상시켜 풍미를 갖게 하는 천연당과 유기산을 다량으로 함유하는 지구자, 서리자, 대조, 갈근, 산사, 모과, 매실, 유자 중에서 선택되는 제2식물생약재군의 발효액 그리고 항산화제, 아스코르빈산 등의 첨가제를 일정 비율로 조성해서 되는 청량음료의 제조방법으로서 이를 구체적으로 설명하면,The present invention relates to a fermentation broth of a first herb medicine group comprising a herbal composition containing a variety of pharmacological components, Angelica keiskei, Angelica keiskei keiskei, Mugwort and Mistletoe, an extract solution obtained by subjecting a fermentation residue of the first herb medicine group to high temperature treatment, A fermentation liquid of a second herb medicine group selected from the group consisting of a large amount of natural sugars and organic acids that impart flavor and a large amount of organic acid, a frost, a control, a paddy field, The present invention relates to a method for producing a soft drink,
◎ 제1식물생약재군의 발효액 제조 방법◎ Method of producing fermentation broth of the first herb medicine group
어성초를 고압 고열의 수증기로 처리하여 불쾌한 냄새(생선비린내와 비슷한 냄새)를 제거한 어성초 40중량부와 당귀, 두충, 오갈피, 겨우살이를 동일한 양으로한 식물생약재 60 중량부로 구성된 제1식물생약재군 100중량부에 설탕 또는 과당 100 중량부를 첨가한 혼합물에 2배 중량의 정수를 첨가하여서 된 제1식물생약재군의 발효재료를 온도 25±2℃로 유지되는 밀폐용기에서 20~25일간 혐기성으로 발효시킨 발효물을 압착 여과하여 제1식물생약재군의 발효잔사를 제거하고 온도 70~80℃에서 10~20분간 살균처리한 제1식물생약재군의 발효액의 제조 방법이다.40 weight parts of the herringbone treated with high-pressure high-temperature water vapor to remove unpleasant odor (odor similar to that of fish flesh), and 100 weight parts of the first herb medicine family comprising 60 weight parts of herbal medicine, herbivorous, Fermented material fermented by anaerobic fermentation for 20 to 25 days in a closed container maintained at a temperature of 25 占 폚 of the first herbal medicines group obtained by adding 2 times the weight of purified water to a mixture containing 100 parts by weight of sugar or fructose Filtering the water to remove the fermentation residue of the first herb medicine group and sterilizing the mixture at a temperature of 70 to 80 ° C for 10 to 20 minutes.
◎ 제1식물생약재군의 발효액의 잔사추출액의 제조Production of residue extract of fermentation broth of first herb medicine group
제1식물생약재군의 발효액잔사에 4배중의 정수를 첨가해서 온도 115~120℃로 유지될 수 있는 고압부에서 1시간 열처리한 다음 상압 하에서 증비하여 전체 중량의 20%가 될 때까지 농축하고 압착하여 제1생약재군의 발효액 잔사추출액을 제조한다.Treated with a quadruplicate in the fermentation residue of the first herb medicine group and heat-treated at a high-pressure part which can be maintained at a temperature of 115 to 120 ° C for 1 hour and then concentrated under atmospheric pressure to 20% Thereby producing a fermentation liquid residue extract of the first herbal material group.
◎ 제2식물생약재군의 발효액 제조 방법◎ Method for producing fermentation broth of the second herb medicine group
지구자, 서리자, 대조, 갈근, 산사, 모과, 매실, 유자를 각각 같은 양으로 구성한 제2식물생약재군의 혼합물에 2배 중량의 정수를 첨가하여 온도20±2℃로 유지된 밀폐용기에서 13~15일간 혐기성 발효로 발효시킨 말효물을 압착 여과하여 발효잔사를 제거하고 온도 70~80℃에서 10~20분간 살균 처리한 발효액의 제조 방법이다.In a sealed container maintained at a temperature of 20 ± 2 ° C by adding 2 times the weight of purified water to the mixture of the second herb medicine group which consisted of the same amount of algae, frostbite, control, The fermentation broth is fermented by anaerobic fermentation for 15 days by filtration to remove the fermentation residue and sterilized at 70 to 80 ° C for 10 to 20 minutes.
◎ 본 발명 청량음료의 제조 방법The present invention relates to a method for producing a soft drink
불쾌한 냄새를 제거한 어성초 40중량부와 당귀, 두충, 오갈피, 겨우살이를 같으량으로 혼합한 식물생약재 60중량부로 구성된 제1식물생약재군의 발효액 34중량부와 제1식물생약재군의 발효액의 잔사추출액 12중량부와 지구자, 서리자, 대조, 갈근, 산사, 매실, 모과, 유자 중에서 선택한 하나 이상의 식물생약재군의 발효액 53중량부 고시풀, 세사물, 레시틴, 세파린, 소맥배아추출물 중에서 선택되는 항산화제 0.8중량부, 아스코르빈산 0.2중량부로 조성되는 어성초를 비롯한 식물생약재를 이용한 청량 음료의 제조 방법이라 할 수 있다.40 parts by weight of herringbone removing unpleasant odor, and 60 parts by weight of plant herb medicine mixed with the same amount of angelica, japonica, acacia and mistletoe were mixed with 34 parts by weight of the fermentation broth of the first herb medicine group and the residue extract 12 of the fermentation broth of the first herb medicine group 53 parts by weight of a fermentation liquid of at least one herbal medicine group selected from the group consisting of weights, globes, frosts, contrasts, browns, hornblends, plums, mosses and citrus fruits; antioxidants selected from the group consisting of herb extracts, lecithin, 0.8 part by weight, and 0.2 part by weight of ascorbic acid.
이상의 청량음료 제조방법에서 제1식물생약재군에 속하는 어성초는 생선비린내가 난다하여 어성초라 부르게 되었다고 하며 실제 생선 비린내와 유사한 불쾌한 냄새가 나며 이를 이용하기 위해서는 이와 같은 냄새를 제거해야 한다.In the above-mentioned method of producing a soft drink, the first herb belonging to the first herb medicine group is called fishbone because of fishy fishy smell, and an unpleasant smell similar to the fishy fishy smell is produced.
어성초에는 0.005%전후의 정유가 함유되어 있다. 그 주성분은 메틸노닐케톤, 데카노일아세트알데히드, 미르?, 라우린알테히드, 카프린알데히드, 카프린산 이밖에도 근간에 기체크로마크그라프에 의하여 28개의 성분이 밝혀진 것으로 알고 있는데 어성초의 불쾌한 냄새는 데카노일아세트알데히드와 라우린알데히드에 의한 것으로 100℃이상의 고압수증기로 처리하면 상기 두성분이 산화되어 변화 생성물인 메틸노닐케톤, 미르?, 카프린산으로 변화되기 때문에 비린내를 제거할 수 있다. 함유된 성분으로서 잎에는 쿠에르치트린과 물에 용해되는 무기성분 2.7%가 함유되어 있고 그 주성분은 칼리움이다 꽃과 열매이삭에는 이소쿠에르치트린이 있다. 쿠에트치트린은 강력한 오줌내기 작용이 있고 대장균, 티프스균, 파라티프스균, 적리균, 림균, 포도상균, 사상균에 대한 항균작용과 모세핏줄 강화작용이 있다. 그 밖에도 어성초 성분에는 비병원성곰팡이는 물론 백선균, 무좀균, 항산성세균에 대한 억균 작용도 있고 포도상균에 대한 항균력은 설파민보다 훨씬 세다.It contains essential oil around 0.005%. The main ingredient is methylnonyl ketone, decanoyl acetaldehyde, myristoyl, laurin aldehyde, capric aldehyde, capric acid, and in addition, we know that 28 compounds were found by gas chromatographic graff, When treated with high pressure steam of 100 ° C or higher due to the use of nonyl acetaldehyde and lauric aldehyde, the two components are oxidized and converted into methylnonyl ketone, myristo, and capric acid, which are changed products. As a contained ingredient, leaves contain 2.7% inorganic component dissolved in quercetrin and water, and its main component is potassium. Flowers and fruit spikes have isoquercetrin. Quetzcitrin has a powerful osmotic effect and has antimicrobial activity against the bacteria such as Escherichia coli, Typhoid fungus, Paratyphoid fungus, Red fungus, Lymphocyte, Staphylococcus aureus and Fungi. In addition, there is a bacterium activity against Phytophthora, Pseudomonas aeruginosa and Acidobacteria as well as non-pathogenic fungi in the strains of Phytophthora infestans.
작용으로서 전초는 염증약, 이뇨해독약으로 임질과 요도염, 방광염, 자궁염, 폐렴, 기관지염, 무좀, 탈홍, 악창 등에 사용하고 차처럼 달여서 매일 복용하면 동맥경화, 풍악 충농증 예방 및 치료에 유효한 것으로 알려져 있다. 예로부터 민간요법으로서는 즙을 내어 헌데, 무좀, 치질 치료에 사용하고 있다.It is known that it is effective for the prevention and treatment of arteriosclerosis, airway inflammation, and the treatment of gout and urethritis, cystitis, pneumonia, pneumonia, bronchitis, athlete's foot, Since ancient times, as a folk remedy, juice has been used to treat boils, athlete's foot, and hemorrhoids.
또한 당귀는 참당귀라고도 하며 성분으로서 전초에 쿠마린 성분이 1.38%, 뿌리에는 2~3%함유되어 있으며 뿌리에서 데쿠르신(용융점 110~111℃), 데쿠르시놀과 같은 피라노쿠마린과 노다케네린, 숨벨리페론, 노다케닌이 분리되었다. 이 밖에 크산토록신 핌피넬린, 오스톨, 움벨리프레닌을 비롯한 많은 쿠마린 성분이 함유되어 있다. 또한 뿌리에는 정유 0.3~0.6%와 수지성분이 있으며 열매에도 데쿠르시놀이 있으며 전초에는 뿌리에서와 같은 정유와 쿠마린이 1%들어 있는데 그 주성분은 역시 데쿠르시놀이다.It is also called as Angelica angustifolia. It contains 1.38% of coumarin and 2 ~ 3% of roots in its outpouring as a component, and decursin (melting point 110 ~ 111 ℃) in the root, pyranocoumarin such as decursinol, , Szumbeliferon, and Nodaikanin were isolated. In addition, there are many coumarin ingredients such as xanthomonas, xanthol, umbelifrenin and xanthine. In addition, the root contains 0.3 ~ 0.6% of essential oil and resin, and the fruit has a decursinol. The outpost contains 1% essential oil and coumarin as in root, and its main ingredient is decursinol.
작용으로 뿌리의 정유 성분은 동물실험에서 진정작용이 있고 때낸 밸에 대하여서는 진정작용이 있는 것으로 알려있고 또한 뿌리의 달임 약도 진정진경작용이 있으며 이러한 작용성분은 정유뿐만 아니라 쿠마린 성분에 의한 것이다. 그것은 크산토록신, 이도핌피넬린, 오스톨, 움벨리프레닌을 비롯한 많은 푸로쿠마린들에서 높은 진경활성이 있다는 것이 알려져 있기 때문이다.The essential oil component of the root is sedative in the animal experiment, and it is known that it has a sedative effect on the vodka that has worn out, and the calming agent of the root has a calming action, and this action component is caused by the coumarin ingredient as well as the essential oil. This is because it is known that there is a high degree of astringent activity in many furos coumarins, including Xanthomas gods, Iodipimpinelin, O stole, Umbelifrenin.
동의치료에서는 진정약, 온성 쟁혈약, 아픔멎이약, 강장약으로 빈혈증과 부인병에 사용하고 있다.In the treatment of bronchial asthma, it is used in sedative medicine, medicinal medicines, pain medication, tonic medicine and in anemia and gynecological diseases.
두충나무는 그 성분으로 잎에는 클로로겐산, 카페산, 아우쿠빈이 함유되어 있고 배당체로선 로가닌이 있으며 또한 헤르파기드 아세타르, 에우콤미올 아유고시드, 레프토시드, 플라보노이드, 알카로이드, 유기산수지, 비타민C 등이 함유되어 있다.It is composed of chlorogenic acid, caffeic acid and aucubin in leaf, and glycosaminoglycan in glycoside. Also, it has herpadic acetat, eucomimol ayugoside, levtoside, flavonoid, alkaloid, organic acid resin , Vitamin C and so on.
작용으로는 나무 껍질과 잎의 달임약 또는 알콜 추출액을 집토끼에서 먹일 때 뚜렷한 혈압내림작용이 있으며 동의 치료에서는 껍질을 강장, 강정, 진정, 아픔멎이 약으로 신허하고 허리가 아픈데, 유정 등에 겨우살이와 쇠무릅뿌리와 함께 쓰며, 두충나무 껍질 달임약은 고혈압, 동맥경화증, 신경아픔근염 허리아플때에 효과가 있다고 알려져 있다.The action of the bark and leaves of the moon or alcohol extract in the rabbit is fed with a distinct blood pressure lowering action in the thyroid gangjeong, Gangjeong, calm, and pain in the mouth is sick and backache, It is said to be effective when used in conjunction with a spikelet root, which is effective when suffering from hypertension, arteriosclerosis, neuropathy, muscle weakness, and back pain.
오갈피는 껍질에 배당체인 알칸토시드, 탄닌질 7%, 정유, 비타민A와 C, 기름이 있다.Alaska pollack has 7% of tannin, essential oils, vitamins A and C, and oil.
정유에는 오갈피나무 껍질의 냄새나는 성분으로 4-메톡시살리찔알데히드가 있고 기름은 팔미틴산, 알라긴산, 리놀산의 글리세리드이다.Essential oil contains 4-methoxy salicylaldehyde as an odoriferous component of the eucalyptus bark, and the oil is glyceride of palmitic acid, alginic acid and linoleic acid.
배당체 성분은 아직 조성이 밝혀지지 않았으나 리그닌핵의 게닌과 여러 가지 당으로 되어 있다. 결합당의 수와 종류에 따라 아칸토시드 A, B, C, D로 나눈다. 배당체 성분은 잎에 많고 또한 γ-시트스테린과 그의 모노글리코시드인 다우코스테린도 함유되어 있으며 또한 리그난핵을 가진 세사민, 사비닌이 있다. 껍질에는 물에 용해되는 다당류가 함유되어 있으며 잎과 꽃에는 플라보노이드, 줄기와 잎 뿌리에는 쿠마린이 함유되어 있고 잎에는 정유, 사포닌 약 0.2%와 탄닌질이 있다. 또한 강심배당체와 알카로이드 확인 반응에 양성 성분이 들어 있다. 최근에 와서 알칸토시드의 게닌이 디페닐-3, 7-디옥시비찌클로-(3,3.0)-옥탄계열의 리그니난 화합물이며 알칸토시드 B와 D가 시린가레시놀의 배당체임이 밝혀졌다.The composition of glycoside is not yet known, but it is composed of several kinds of sugars and lignin nucleus. It is divided into acanthoside A, B, C, D according to the number and type of binding sugar. The glycoside component is also contained in the leaves, and also contains dacosterol, which is γ-sitestrel and its monoglycoside, and sesamin and sabinin, which have leukocyte nucleus. The shells contain polysaccharides dissolved in water, leaves and flowers contain flavonoids, stem and leaf roots contain coumarin, leaves contain essential oil, saponin about 0.2% and tannic acid. It also contains positive components in the cardiac glycoside and alkaloid identification reactions. Recently, it has been found that the alkanosides B and D are glycosides of the cyclin resinol, and the alkanocides B and D are glycosides of diphenyl-3,7-dioxybicyclo- (3,3.0) -octane-based lignin compounds.
작용으로 뿌리 우림약은 정신적 육체적 피로를 회복시키며 항염증, 아픔멎이 작용이 있고 뿌리의 추출액과 배당체는 중추신경통에 대한 긴장작용이 있으며 유기체의 비특이적 저항성을 높여준다.Root-rain forest medicine restores mental and physical fatigue, anti-inflammation, and pain relief. Root extracts and glycosides have a tonic effect on the central nervous system and increase nonspecific resistance of organisms.
동의 치료에서는 강장, 이수, 거습, 아픔멎이약으로 몸이 쇠약할때와 관절염, 신경아픔, 신경성소화불량, 각기 허리아픔, 임신통증, 건위, 감기 등에 사용하고 있다.It is used for the treatment of joints, ischemia, hypertension, pain, weakness of the body, arthritis, nerve pain, nervous dyspepsia, back pain, pregnancy pain, dryness and cold.
겨우살이는 금은화 또는 인동덩굴이라고도 불리고 있는 사철 푸른 떨기나무로 성분으로 꽃에는 루테올린, 이노시톨 성분이 함유되어 있고 쩨릴알콜, 스테린, 아라킨산, 미리스틴산, 엘라이딘산, 리놀산도 함유되어 있다. 잎과 줄기에는 5~8% 탄닌질이 있고 잎에는 로가닌, 약 19%의 함질소물질 그리고 루테올린-7-람노글루코시드인 로니쩨린도 있다.Mistletoe is a component of the evergreen bush that is also called gilt euphonium or rhododendron. Flowers contain luteolin and inositol. It also contains tylic alcohol, stearin, arachic acid, myristic acid, elaidic acid and linoleic acid . There are 5 to 8% tannin in the leaves and stems, about 19% in nitrogen in the leaves, and Ronitzerin, a luteolin-7-rhamnoglucose.
꽃 달인물은 오줌낵기 작용이 있고 적리균, 티프스균, 포도상균, 폐염균에 센 억균 작용이 있으며 소화성 위궤양의 예방효과가 있는 것으로 알려져 있다. 동의 치료에서 꽃과 잎, 줄기를 열내림약, 독풀이약, 오줌내기약, 쟁혈약, 풍악의 초기, 종창과 종독, 여러 가지 창독, 곪는 질병에 사용하고 있다. 민간에서는 암 치료에 사용하고 있고 차처럼 오래 먹으면 위암에 좋다고 알고 있다. 그 밖에 인동덩굴 달임약으로 특히 자궁내막염, 임파성 결핵의 루공, 입안염때 씻거나 입가심한다. The flower moon character has a peepering action, and it is known to have a preventive effect of peptic gastric ulcer, and has an antimicrobial action in the aerobic bacteria, typhoid bacteria, grape aseptic bacteria, and pneumococcal bacteria. It is used in the treatment of flowers and leaves, stalks for fever reduction medicine, poison drugs, poison drugs, early onset of wind, swelling and poisoning, various dermatitis and swelling diseases. It is used for cancer treatment in the private sector and it is good for stomach cancer if it eats for a long time like tea. In addition, it is an indigo vinegar myrrh, especially in endometritis, lumen of lymphatic tuberculosis, and it is washed or bloomed in the mouth.
또한 본 발명 청량음료 제조에 사용된 제2식물생약재군에 속하는 실물생약재로서 갈근은 그 성분으로 뿌리에는 이소플라본 화합물인 다이드제인, 푸에라린, 푸에라린크실로시드, 루테올린, 비오카닌, 농마, 쿠마린이 함유되어 있으며 또한 콜린, 카크코네인, 푸에라롤이 분리되었다.Also, as a real herbal medicine belonging to the second herb medicine group used for the production of soft drinks of the present invention, Puerariae is a component thereof, and its roots include isoflavone compounds such as daidzein, fuerarin, fuerarin xyloside, luteolin, Ninh, horsetail, and coumarin were also contained, and choline, kakoneine and fuerarol were also isolated.
잎에는 쿠마린, 아데닌, 아스파라긴, 글루타민산, 켐페롤-람노시드, 로비닌 등이 함유되어 있고 꽃에는 로비닌, 이리솔리돈, 게니스테인, 다이드제인, 쿠에르치트린 등의 플로보노이드와 정유성분으로 핵산, 벤질알콜, 오이게놀, 이소아밀알콜, 초산에틸, 옥틸알콜, 페네릴알콜, L-리날롤이 함유되어 있다. 이 밖에 안식향산, 프로피온산, P-쿠마르산, 카프론산이 들어 있다.The leaves contain coumarin, adenine, asparagine, glutamic acid, camperol-lamboside, and rubinin. Flowers contain flownoids such as Robinin, Ilysolidon, Genistein, Daidzein and Cuercitrin, Components include nucleic acids, benzyl alcohol, ogenol, isoamyl alcohol, ethyl acetate, octyl alcohol, penalyl alcohol and L-linalool. In addition, it contains benzoic acid, propionic acid, P-cumaric acid, and caproic acid.
작용으로는 온열중추를 자극한 집토끼에게 뿌리가루 15g/kg을 먹이면 뚜렷한 열내림 작용이 있고 다른 이상은 없다. 물이나 알콜 추출액 역시 열내림 작용이 있으나 물 추출액의 효과가 크다. 열내림 작용은 합성해열제보다 늦게 나타나지만 지속 시간은 아주 길다.In action, feeding rabbit 15g / kg to rabbits that stimulate the central heat has a pronounced thermal decline and no other abnormalities. Water and alcohol extract also have a thermal effect, but the effect of water extract is great. The thermal decay appears later than the synthetic antipyretic, but the duration is very long.
뿌리의 이소플라본 화합물은 진경작용이 있고 특히 이 작용은 다이아제인에서 세다. 또한 다이드제인을 편두통, 고혈압, 협심증 여러 가지 심장의 대상 기능부전증에 사용한 결과 심장핏줄을 확장하며 환자에게 치료 효과가 있었다. 또 잎과 꽃에 있는 로비닌은 오준내기 작용, 특히 핏속의 잔여질소함량을 줄이는 작용을 한다. 총플라보노이드는 혈압을 낮추고 뇌피줄 및 관상동맥의 피흐름량을 늘이고 심근의 산소소비량을 낮추고 핏속 산소 공급량을 늘린다. 동의 치료에서 뿌리와 꽃은 발한 해열약, 진경약으로 열병에 쓰며 목안이 마르고 머리가 아플 때, 감기로 머리와 목이 아플 때, 편도염, 급성중이염에 사용하고 있으며 그리고 어혈을 풀고 상처를 아물게 하는데 사용하고 있다.Isoflavone compounds in roots have an epidermal action, and this action is particularly severe in diazenes. The use of daidzein in migraine, hypertension, angina pectoris, and cardiac dysfunction has resulted in a wider range of cardiovascular and therapeutic effects. Robinin in leaves and flowers also acts to reduce the Ojun's action, especially the residual nitrogen content of the blood. Total flavonoids lower blood pressure, increase blood flow to the brain and coronary arteries, lower myocardial oxygen consumption and increase blood oxygenation. Root and flowers are used for fever, fever, fever, fever, fever, dry mouth, headache, sore throat and acute otitis media. .
지구자는 갈매나무과에 속하는 헛개나무의 열매로 둥글고 붉은 색을 띠며 단맛이 있으며 포도당, 서당, 과당, 천연당과 카달라제, 페록시타제 등의 효소가 함유되어 있으며 총당의 함량은 13%이고 그 밖에 트리테르페노이드인 호베니산, 루틴이 들어 있고 동의 치료에서는 오줌내기, 독풀이 약으로 술독을 풀어 주는데 효과가 있다.The globe is a fruit of the humpback tree belonging to the Seedlings. It is round, red and sweet, and contains enzymes such as glucose, sucrose, fructose, natural sugar, cadaladate and peroxidase. The content of total sugar is 13% It contains triterpenoid, hobenic acid, and rutin, and it is effective in relieving digestion with urine and other medicines.
서리자는 갈매나무과에 속하는 갈매나무의 열매로서 그 성분으로는 켐페롤과 그 배당체가 약 8%함유되어 있으며 크리소파놀과 안트론, 기름 11%가 함유되어 있다. 기름의 주성분은 팔미틴산, 스테아린산, 리놀산, 리놀레인산 등 이고 그 밖의 성분으로 크리사로빈, 에모딘, 안트론이 함유되어 있으며 동의 치료에서는 오줌내기약, 위장질병, 특히 열매 추출물은 항암약으로 사용하고 있다.Frostbite is a fruit of the Seagrass that belongs to the Seagrass family, which contains about 8% of Chemperol and its glycosides, and contains 11% of Crissopanol, Anthrone, and Oil. The major components of the oil are palmitic acid, stearic acid, linoleic acid, linoleic acid, etc. Other components are chrysarobin, emodine and anthrone. In the case of copper therapy, ozone medicines, gastrointestinal diseases, especially fruit extracts are used as anticancer drugs .
생 대조에는 건물질이 20~49%있으며 이중 14~42%가 과당, 서당, 포도당, 람노르로 구성되어 있다. 전체 당 중 과당이 34~35%를 차지한다. 그 외 싱아산, 호박산, 사과산, 사과산 글리콜산과 같은 유기산이 0.54~3.4% 함유되어 있다. 무기질로는 회분이 1.15%까지 함유되어 있는데 그의 절반이 카리움 성분이다. 그 밖에 Na, Mg, Ca, P, Fe, Mn, Zn, Cu, Co, Ni, Ba, St의 미량성분이 함유되어 있다. 또한 대조에는 살구, 사과, 포도와 같은 과일보다 인은 8배, 칼시움은 6배, 코발트는 4배, 요오드는 2배나 많다. 또한 열매에는 1.9~2.2%의 단백질이 들어 있으며 지스틴, 리신, 아르기닌, 아스파라긴산, 트레오닌, 알라닌 티로신, 아미노지방산, 프롤린, 메티오닌, 발린, 그네니알라닌, 로이찐, 이소로이찐 등 14개의 아미노산이 확인되었다.There are 20 to 49% of dry matter in the raw control, 14 to 42% of which is composed of fructose, sucrose, glucose, and laminar. Fructose accounts for 34 ~ 35% of total sugar content. In addition, 0.54 to 3.4% of organic acids such as succinic acid, succinic acid, malic acid and malic acid glycolic acid are contained. Minerals contain up to 1.15% ash, half of which is a component of carium. In addition, trace elements of Na, Mg, Ca, P, Fe, Mn, Zn, Cu, Co, Ni, Ba and St are contained. In contrast, phosphorus is 8 times more than fruits such as apricots, apples and grapes, 6 times more calcium, 4 times more cobalt, and 2 times more than iodine. The fruit also contains 1.9 to 2.2% of protein and contains 14 amino acids including gystine, lysine, arginine, aspartic acid, threonine, alanine tyrosine, amino fatty acid, proline, methionine, valine, .
또한 아스코르빈산이 유리형, 결합형, 환원형으로 있으며 카테킨과 로이코안토찌안, 플라보노이드로 이루어진 비타민P도 함유되어 있으며 카테킨으로서는 (-)에피갈로카텐인, (+)갈로카테인, (-)에피갈로카테킨갈라드, 플로보노이드로서는 쿠에르치트린, 루틴이 분리되었다. 잎에는 9%의 탄닌질, 3.7%의 플라보노이드, 쿠마린, 사포닌, 당, 우론산, 수지정유, 아스코르빈산, 카로틴, 엽산, 비타민B1이 있다. 플라보노이드로는 쿠에르치트린과 루틴이 있고 또한 잎에는 0.017~0.031%의 알카로이드가 있으며, 코크라우딘, 이소볼르딘, 노르이소볼르딘, 아시밀로빈, 유자린, 유지핀, N-메틸-코클라우린 등 벤질테트라히드로 이소키놀린계 알카로이드가 분리되었다.(-) epigallocatechin, (+) galactatein, (-) galactanine, and (-) catechin, which are vitamins of catechin, leucoanthan and flavonoids. ) Epigallocatechin gallate, and as a fluroboronide, quercetitrin and rutin were separated. The leaves contain 9% tannin, 3.7% flavonoid, coumarin, saponin, sugar, uronic acid, resin essential oil, ascorbic acid, carotene, folic acid, vitamin B 1 . The flavonoids are quercetrin and rutin, and the leaves contain 0.017 to 0.031% of alkaloids and include cocroudine, isoborudin, norisobordine, asymilobin, yuzarin, retentate, N-methyl- A benzyltetrahydroisoquinoline alkaloid such as cochlein was isolated.
그 밖에 씨에는 카프린산, 팔미틴산, 올레인산, 스테아린산, 리놀산의 글리세리드인 기름이 21~33% 함유되어 있다.Other seeds contain 21-33% oil, which is a glyceride of capric acid, palmitic acid, oleic acid, stearic acid and linoleic acid.
작용으로는 잎의 추출물은 혈압을 낮추며 심장의 율동을 느리게 하며 대뇌피질을 억제하여 진정효과도 있다. 또한 대조 열매의 우림약도 고혈압 환자에 사용할 경우 혈압과 혈액지표가 정상으로 됨으로서 좋은 치료 효과가 있으며 특히 피속의 비타민C 농도가 매우 높아지고 프로트롬빈이 적어졌다. 이러한 혈압 내림 작용은 대조에 함유된 비타민P와 비타민C가 많으므로 이물질의 상호 협력 작용으로 상승효과를 나타내는 것으로 되어 있다. 열매에는 또한 Fe, Mn, Cu, Co 등의 함량이 많으므로 피가 적은 병 치료에 효과가 있는 것으로 알려져 있고 특히 대조는 아데닐찌클라제 활성 및 포스포디에스테라제 활성이 있어 바로 이것이 대조의 항알레르기성 활성물질이라고 하고 있다. 응용분야는 오줌내기약, 염증약으로 심장부전증, 콩팥질병, 진정약에 사용되고 동의 치료에서는 완화약, 오줌내기약, 강장약, 근육이 쫄아드는 질병, 지각과민증, 기침, 곪긴데에 사용하고 있다. As an action, the leaf extract lowers blood pressure, slows the heart's rhythm, and suppresses the cerebral cortex. In addition, when used in patients with hypertension, the blood pressure and blood index are normalized, and thus the therapeutic effect is good. Especially, the concentration of vitamin C in blood is very high and the prothrombin is decreased. This blood pressure lowering action has a synergistic effect due to mutual cooperation of foreign substances because there are many vitamin P and vitamin C contained in the control. Since the content of Fe, Mn, Cu, Co, etc. is also high in the fruit, it is known that it is effective for the treatment of less blood. In particular, the control has adenylatecholase activity and phosphodiesterase activity, It is said to be an allergic active substance. The application field is used for ozone drug, inflammation drug for cardiac insufficiency, kidney disease, sedative drug. In the case of copper therapy, it is used for relief medicine, urinary ophthalmic drug, tonic medicine, muscular scraping disease, hypersensitivity, cough,
또한 모과는 열매에 사과산 유기산, 사포닌 탄닌질이 함유되어 있으며 동의치료에서 기침멎이, 아픔멎이, 이수, 각기, 허리아픔, 뼈마디아픔 등의 처방에 사용되고 있다.In addition, the fruit of the fruit contains malic acid, saponin tannin, and it is used for cough treatment, acne, toothache, sepsis, back pain, bony pain and so on.
산사는 장미과에 속하는 찔광이 나무의 열매로서 그 성분으로 우르솔산, 아미그달린, 글루로겐산, 레몬산, 포도주산을 비롯한 다양한 유기산 플라보노이드, 비타민C가 함유되어 있으며 그 밖에도 올레아놀산, 아스코르빈산, 카페산, 히페로시드, 탄닌질, 소르비트, 콜린, 지방산 β 시트스테린, 아미노폴린, 아데노신, 아데닌, 구아닌 등이 함유되어 있다. 열매 속의 씨에는 아미그달린, 히페로시드 지방산이 들어 있다. 작용으로는 심근에 대한 강심작용이 있고 혈액순환을 원활하게 하며 콜레스테린 함량을 줄이고 혈압을 내린다.It is a fruit of the tree belonging to Rosaceae. It is a fruit of the tree. It contains various organic acid flavonoids and vitamins C such as urosol, amigalline, glurogenic acid, lemon and wine, and also contains oleic acid, ascorbic acid, Sorbitol, choline, fatty acid beta-sitosterol, aminoproline, adenosine, adenine, guanine and the like. The seeds in the fruit contain Amigalline and Hiperocide fatty acids. It has a cardiovascular effect on the myocardium, smoothes blood circulation, reduces cholesterol content and lowers blood pressure.
매실은 잘 알려진 바와 같이 발효식품으로 널리 이용되고 있는 매화나무 열매로서 성분으로는 레몬산, 사과산, 포도주산, 호박산, 스트스테롤 오레아놀산, 세틸알콜 아미그달린 등의 성분이 함유되어 있으며 동의 치료에서 청량성 수렴약, 설사멎이약, 기침약의 처방에 사용되어 왔다.As well known, plum fruit is widely used as a fermented food, and its ingredients include lemon, malic acid, wine acid, succinic acid, sterolol oleanolic acid, cetyl alcohol amidualin, It has been used in the prescription of astringent, diarrhea, and cough medicine.
유자에는 과당, 에스코시드%가 함유되어 있으며, 에코시드는 사탕의 300배의 단맛이 있고 트리테르펜에 5분자의 포도당이 붙은 배당체이다. 민간요법으로는 설사, 위장병에 사용하고 있으며 기침멎이, 열내림약, 백일기침에 효과가 있다. Yuza contains fructose, escoside%, and ecoside is a glycoside with 300 times sweetness of candy and five molecules of triterpene with glucose. Folk remedies are used for diarrhea and gastrointestinal illness, and are effective for coughing, fever reduction, and fever cough.
이상에서 설명한 제1식물생약재군은 제2식물생약재군에 비해 약리적인 성분이 많고 고온(100℃이상)에서 용출되는 성분이 많으며 건강음료로서의 약리적인 기능과 작용을 확보할 수 있는 식물생약재들이라 할 수 있고 제2식물생약재군은 음료로서의 맛의 향상으로 풍미를 즐길 수 있는 성분이 다량으로 함유된 식물생약재들이라 할 수 있다. As described above, the first herb medicine group has more pharmacological components than the second herb medicine group and has many components eluted at a high temperature (100 ° C or higher). It can be said that they are phytopharmaceuticals that can secure pharmacological functions and actions as health drinks And the second herb medicine group is a herb medicine containing a large amount of ingredients capable of enjoying flavor due to improvement of taste as a beverage.
또한 식물생약재의 성분 중에는 물 또는 유기용제 모두에 용출되는 성분이 있는가하면 물 또는 용제에 선택적으로 용출되는 성분이 있다. 그러나 추출에 의한 방법으로 약재나 건강식품을 위해서는 유해성을 고려 유기용제의 사용을 극히 제한하고 있다.In addition, the components of the plant herbal medicine include components eluted in both water and organic solvents, and components eluted selectively in water or solvent. However, in the case of medicines and health foods, the use of organic solvents is extremely limited in consideration of harmfulness.
식물생약재물로 추출할 경우보다는 식물생약재를 발효시켜 추출하는 경우에 성분의 추출회수율을 높일 수 있고 발효 숙성 과정에서 우수한 식감을 갖는 유기산을 비롯한 유용한 성분을 생성시킬 수 있어 추출효율이나 식감의 향상 측면에서 유리하다.In case of extraction by fermentation of plant herbal medicines rather than extracting with plant herb medicine, it is possible to increase extraction recovery rate of components and to produce useful components including organic acid having excellent texture in fermentation aging process, thereby improving extraction efficiency and texture .
본원 발명 제2식물생약재군은 제1식물생약재군에 비해 약리적인 성분이 덜하나 상술한 바와 같이 향취와 풍미를 더하는 천연당과 다양한 유기산이 많이 함유된 식물생약재들로서 제1식물생약재에 비해 낮은 온도에서도 물에 쉽게 용출되는 성분이 많아 제1식물생약재의 발효잔사는 고온 처리를 해도 추출 효율을 크게 기대할 수 없다.As described above, the second herb medicine group of the present invention has less pharmacological components than the first herb medicine group. However, as described above, the herbal medicine herb contains a lot of natural sugars and various organic acids, The extraction efficiency can not be expected to be high even if the fermentation residue of the first plant herb medicine is treated at a high temperature.
이와 같은 방법으로 얻어진 청량음료는 제1식물생약재군의 어성초의 성분, 기능 및 작용에서 알 수 있듯이 어성초에는 쿠에르치트린이란 성분이 함유되어 있어 대장균, 디프스균, 파라티르스균, 적리균, 림균, 포도상균, 사상균에 대한 항균작용이 있고 각종 염증질병에 효과가 있고 두충 또한 적리균, 티프스균, 폐염균, 포도상균에 대한 강력한 억균 작용이 있어 장복할 경우 다양한 질병성 세균에 대해서 감염이 없고 염증성 질병에 감염되지 않으며 피부질병이 발생하지 않는다.As can be seen from the components, functions and actions of the herbicide of the first plant herb medicine group, the soft drink obtained by this method contains the component of quercetin linin in the herbaceous plant, and thus, the coliform, the diphtherus, the parathorm, It has antimicrobial activity against grape germs and molds and is effective against various inflammatory diseases. It has strong infectious effect against agrobacterium, typhoid, pneumococcal and grape germs, so that when infected, there is no infection against various disease bacteria and inflammatory diseases And skin disease does not occur.
또한 제2식물생약재에 의한 다양한 천연당, 유기산에 의해 음료로서의 식감을 크게 향상시킬 수 있어 풍미를 즐길 수 있는 청량음료라 할 수 있다.In addition, a variety of natural sugars and organic acids produced by the second herb medicine can significantly improve the texture of beverages, so that they can be enjoyed as a refreshing drink.
Claims (5)
상기 제1식물 생약재군의 발효물 잔사에 4배 중량의 정수를 첨가하여 110~120℃로 유지시킨 고압부에서 1시간 열처리 후 상압하에서 끓여 전체 중량의 20%가 될 때까지 농축하고 압착 여과하여 얻어진 제1식물 생약재군의 발효물 잔사 추출액을 얻는 2단계 공정
지구자, 서리자, 대조, 갈근, 산사, 모과, 유자, 매실을 각각 동량으로 배합한 제2식물 생약재군의 혼합물에 2배 중량의 정수를 가하여 온도 25±2℃에서 13~15일간 혐기성 발효로 발효시킨 발효물을 압착 여과한 여액을 온도 70~80℃로 10~20분간 살균 처리한 제2식물 생약재군의 발효액을 얻는 3단계 공정
상기 제1식물 생약재군의 발효액 34중량부, 제1식물 생약재군의 발효물 잔사 추출액 12중량부, 제2식물 생약재군의 발효액 53중량부, 항산화제 0.8중량부, 아스코르빈산 0.2중량부를 혼합 균질화시키는 4단계 공정으로 구성되는 어성초를 비롯한 식물생약재를 이용한 청량음료의 제조 방법To the mixture of 100 parts by weight of the first herb medicine group consisting of 40 parts by weight of herringbone and 60 parts by weight of plant herb medicine mixed with the same amount of Angelica keiskei, Angelica keiskei, Ocarpi and Mistletoe, 100 parts by weight of sugar or fructose was added, The fermented material obtained by fermenting the fermented material fermented by anaerobically fermenting the fermented material for 20 to 25 days at a temperature of 25 ± 2 ° C is filtered to remove the fermented material residue of the first plant herbicide group and the filtrate is sterilized at 70 to 80 ° C for 10 to 20 minutes To obtain a fermentation broth of the first herb medicine group;
The fermentation product residue of the first herb medicine group was added with a quadruple weight constant and heated at a high pressure of 110 to 120 ° C for 1 hour, boiled under normal pressure, concentrated to 20% of the total weight, Two step process to obtain fermented residue extract of the first herb medicine group
2 times the weight of purified water is added to the mixture of the first herb medicine group, the second herb medicine group, and the second herb medicine group, which are mixed with the same amounts, respectively, to the anaerobic fermentation broth for 13 to 15 days at 25 ± 2 ° C. A fermentation broth of the second herb medicine group obtained by filtration of the fermented fermented product by filtration and sterilized at a temperature of 70 to 80 ° C for 10 to 20 minutes,
34 parts by weight of the fermentation broth of the first herb medicine group, 12 parts by weight of the fermentation residue extract of the first herb medicine group, 53 parts by weight of the fermentation broth of the second herb medicine group, 0.8 part by weight of the antioxidant and 0.2 parts by weight of ascorbic acid A method for manufacturing a soft drink using a plant herb medicine including a four-step process of homogenizing
어성초는 100℃ 이상의 고압증기로 처리하여 어성초에 함유된 데카노일 아세트 알데히드와 라우린 알데히드를 산화시켜 메틸노닐케톤, 미르? 카프린산으로 변환시킨 어성초임을 특징으로 하는 청량음료의 제조 방법The method according to claim 1,
Hwasungcho is treated with high pressure steam at 100 ℃ or higher to oxidize decanoyl acetaldehyde and lauric aldehyde contained in the perennial herb to produce methylnonyl ketone, A method for producing a soft drink characterized by being a perennial herb converted into capric acid
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120137489A KR101404309B1 (en) | 2012-11-30 | 2012-11-30 | The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120137489A KR101404309B1 (en) | 2012-11-30 | 2012-11-30 | The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101404309B1 true KR101404309B1 (en) | 2014-06-05 |
Family
ID=51132010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120137489A KR101404309B1 (en) | 2012-11-30 | 2012-11-30 | The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101404309B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101540069B1 (en) * | 2014-12-26 | 2015-07-29 | 농업회사법인정담아(주) | Asparagus tuber fermentation sap liquid, and manufacturing method thereof |
KR101634668B1 (en) | 2015-07-27 | 2016-06-30 | 강원대학교산학협력단 | Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening |
KR101935538B1 (en) | 2017-03-23 | 2019-01-04 | 배영미 | Mixture of extract or fermentation using Allium tuberosum and production method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050079256A (en) * | 2004-02-05 | 2005-08-10 | 주식회사 리젠 바이오텍 | Composition for preventing and treating allergic diseases comprising extracts of houttuynia cordata and rubus coreanus |
KR100568090B1 (en) | 2003-11-06 | 2006-04-05 | 박용한 | A drink composition of the fermented Houttuynia cordata thunb |
KR20090123458A (en) * | 2008-05-28 | 2009-12-02 | 주식회사 엘씨에스바이오텍 | A method for fermentation of natural plants or herbal medicines, a fermented product prepared therefrom and a cosmetic composition, a food composition and a pharmaceutical composition comprising the same |
KR20100101258A (en) * | 2009-03-09 | 2010-09-17 | 주식회사 엘씨에스바이오텍 | Methods for fermentation of natural plants or herbal medicines and fermented products using the same methods |
-
2012
- 2012-11-30 KR KR1020120137489A patent/KR101404309B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100568090B1 (en) | 2003-11-06 | 2006-04-05 | 박용한 | A drink composition of the fermented Houttuynia cordata thunb |
KR20050079256A (en) * | 2004-02-05 | 2005-08-10 | 주식회사 리젠 바이오텍 | Composition for preventing and treating allergic diseases comprising extracts of houttuynia cordata and rubus coreanus |
KR20090123458A (en) * | 2008-05-28 | 2009-12-02 | 주식회사 엘씨에스바이오텍 | A method for fermentation of natural plants or herbal medicines, a fermented product prepared therefrom and a cosmetic composition, a food composition and a pharmaceutical composition comprising the same |
KR20100101258A (en) * | 2009-03-09 | 2010-09-17 | 주식회사 엘씨에스바이오텍 | Methods for fermentation of natural plants or herbal medicines and fermented products using the same methods |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101540069B1 (en) * | 2014-12-26 | 2015-07-29 | 농업회사법인정담아(주) | Asparagus tuber fermentation sap liquid, and manufacturing method thereof |
KR101634668B1 (en) | 2015-07-27 | 2016-06-30 | 강원대학교산학협력단 | Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening |
KR101935538B1 (en) | 2017-03-23 | 2019-01-04 | 배영미 | Mixture of extract or fermentation using Allium tuberosum and production method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101501326B1 (en) | Manufacturing method of the composition using 125 kinds of medicinal herb extracts | |
KR20130047778A (en) | Fermentation method using medicinal flower and skin external composition containing fermented extract by the method | |
KR101541516B1 (en) | Mathod Manufacturing lON Mineral Using Silk worm, Muberry leaf, and Muberry twig And Health Drink Manufactured by this | |
KR20110112231A (en) | Fermentation method using medicinal leaf and skin external composition containing fermented extract by the method | |
KR20160087114A (en) | Food additive containing flowers | |
CN103622111A (en) | Preparation method of golden pomelo and glutinous rice vinegar beverage and golden pomelo and glutinous rice vinegar beverage prepared by method | |
KR20160087112A (en) | Flower tea and method for manufacturing therof | |
KR100867514B1 (en) | How to manufacture a soap from lithospermum erythrorhizon | |
CN101411488A (en) | Ginseng fruit tea | |
CN111528381A (en) | Heat-clearing fire-reducing sore-throat-relieving plant beverage and preparation method thereof | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
KR101404309B1 (en) | The method of preparing clear and cool drink using the traditional oriental medicine of plant including polypara codata bueck | |
KR20090098024A (en) | The method of manufacturing of medicinal wine | |
KR102577074B1 (en) | Manufacturing method of homemade snack of fishery products keeping its original form for companion animal and homemade snack of fishery products keeping its original form for companion animal manufactured using the method | |
KR101333152B1 (en) | Honey containing lavender | |
KR20120121468A (en) | anhydrous lactobacillus fermentation health function food composition with sex funstion improvements effects | |
CN105985895A (en) | Health-preserving wine and preparation technique thereof | |
KR101999675B1 (en) | Herbal composition for the prevention and treatment of coronary heart disease | |
CN106497722B (en) | Walnut flower pomegranate fruit wine and preparation method thereof | |
CN111557363B (en) | Oil-removed hawthorn lotus leaf tea beverage and preparation method thereof | |
CN107904092A (en) | A kind of refrigerant light-alcohol yellow rice wine and its preparation process | |
KR20110090217A (en) | Anhydrous lactobacillus fermentation health function food composition with sex funstion improvements and its preparation method | |
CN105124076A (en) | Healthy tea capable of moistening throat and preparing method thereof | |
Singh et al. | VALUE ADDITION TO FOREST PRODUCE FOR NUTRITION AND LIVELIHOOD. | |
CN104721248B (en) | Composition with antidepressant effect and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170518 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180509 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20200114 Year of fee payment: 6 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20200203 Year of fee payment: 7 |